Q3 2020

Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001683168-20-003871

Q3 2020 · 10-Q

Revenue

$115.93K

— vs Q3 2019

Net Income

-$7.56M

N/M vs Q3 2019

EPS Diluted

-$1.20

N/M vs Q3 2019

Operating Income-$10,504,404N/M

Operating Cash Flow

Same quarter

Metric	Q3 2020	Q3 2019	Q3 2018	Q3 2017
Revenue	$115.93K	$0.00	$0.00	$85.00K
Net Income	-$7.56M	-$8.90M	-$1.81M	-$2.26M
EPS Diluted	-$1.20	-$2.67	-$2.31	-$0.26

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR